Background Few studies have assessed participant safety in human challenge trials (HCTs).
Key questions regarding HCTs include how risky such trials have been, how often adverse …

Human challenge trials (HCTs) are a potential method to accelerate development of vaccines
and therapeutics. However, HCTs for COVID‐19 pose ethical and practical challenges, in …

Members of the Borrelia burgdorferi paralogous gene family 54 (pgf 54) are regulated by
conditions simulating mammalian infection and are thought to be instrumental in borrelial host …

This paper describes the development and preparation of a new class of materials for
surface-enhanced Raman scattering (SERS) consisting of gold nanoparticles coated onto hollow, …

Borrelia burgdorferi, the causative agent of Lyme disease in the United States, regulates
numerous genes encoding lipoproteins on linear plasmid 54 in response to environmental cues…

Borrelia burgdorferi, the etiological agent of Lyme disease in humans, is vectored between
mammalian hosts in nature by Ixodes ticks. The organism adapts to diverse environments …

As adherence and entry of a pathogen into a host cell are key components to an infection,
identifying the molecular mechanisms responsible for cellular association will provide a better …

Borrelia burgdorferi infection causes Lyme borreliosis in humans, a condition which can involve
a systemic spread of the organism to colonize various tissues and organs. If the infection …

In human challenge trials, volunteers are deliberately infected with a pathogen to accelerate
vaccine development and answer key scientific questions. In the US, preparations for …

Plague seroprevalence was estimated in populations of pumas and bobcats in the western
United States. High levels of exposure in plague-endemic regions indicate the need to …